Wendy Chan
Chief Executive Officer bei LODE GOLD RESOURCES INC.
Vermögen: 42 320 $ am 31.03.2024
Profil
Wendy T.
Chan is the founder of Moxie Strategy, Inc., Care Point Medical & Wellness Clinics.
She currently holds the position of Chief Executive Officer & Director at Lode Gold Resources, Inc. since 2023, Independent Director at Riverside Resources, Inc. since 2022, and Director at Mandala Capital, Inc. since 2022.
Previously, she worked as a Business Director at Johnson & Johnson, Janssen Pharmaceuticals, Inc., Aurora Cannabis, Inc., GlaxoSmithKline, Inc., and Janssen, Inc. She also served as a Director at Bc Cancer Foundation and held the position of Business Director at NexGen Hearing.
Additionally, she worked as the Vice President-Corporate Development at Skeena Resources Ltd.
Ms. Chan completed her MBA from McGill University and holds an undergraduate degree from the University of British Columbia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LODE GOLD RESOURCES INC
0,41% | 04.03.2024 | 900 000 ( 0,41% ) | 21 600 $ | 31.03.2024 |
MANDALA CAPITAL INC
6,15% | 10.02.2023 | 560 000 ( 6,15% ) | 20 720 $ | 31.03.2024 |
RIVERSIDE RESOURCES INC.
-.--% | 17.01.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Wendy Chan
| Unternehmen | Position | Beginn |
|---|---|---|
| MANDALA CAPITAL INC. | Director/Board Member | 01.05.2022 |
| RIVERSIDE RESOURCES INC. | Director/Board Member | 01.03.2022 |
| LODE GOLD RESOURCES INC. | Chief Executive Officer | 19.12.2023 |
Ehemalige bekannte Positionen von Wendy Chan
| Unternehmen | Position | Ende |
|---|---|---|
| Bc Cancer Foundation | Director/Board Member | - |
| AURORA CANNABIS INC. | Corporate Officer/Principal | - |
NexGen Hearing
 NexGen Hearing Medical SpecialtiesHealth Technology NexGen Hearing provides hearing healthcare products and services. | Corporate Officer/Principal | - |
Janssen, Inc.
 Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Ausbildung von Wendy Chan
| McGill University | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| SKEENA RESOURCES LIMITED | Non-Energy Minerals |
| RIVERSIDE RESOURCES INC. | Non-Energy Minerals |
| AURORA CANNABIS INC. | Process Industries |
| Private Unternehmen | 9 |
|---|---|
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
| Lode Gold Resources, Inc. | |
| Bc Cancer Foundation | |
NexGen Hearing
NexGen Hearing Medical SpecialtiesHealth Technology NexGen Hearing provides hearing healthcare products and services. | Health Technology |
| Mandala Capital, Inc. | |
| Moxie Strategy, Inc. | |
| Care Point Medical & Wellness Clinics |
